CME Group Inc (NASDAQ:CME) insider Derek Sammann sold 6,400 shares of the business’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $198.83, for a total transaction of $1,272,512.00. Following the completion of the sale, the insider now directly owns 25,177 shares of the company’s stock, valued at approximately $5,005,942.91. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
CME Group stock traded up $1.14 during midday trading on Friday, reaching $202.81. 884,617 shares of the stock traded hands, compared to its average volume of 1,343,509. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.16. The stock has a fifty day moving average price of $194.49. The firm has a market cap of $72.41 billion, a price-to-earnings ratio of 29.74, a price-to-earnings-growth ratio of 4.59 and a beta of 0.23. CME Group Inc has a fifty-two week low of $158.35 and a fifty-two week high of $204.56.
CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, May 1st. The financial services provider reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.60 by $0.02. The firm had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.19 billion. CME Group had a net margin of 42.47% and a return on equity of 9.29%. CME Group’s revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.86 EPS. On average, research analysts expect that CME Group Inc will post 6.7 EPS for the current year.
A number of brokerages recently weighed in on CME. UBS Group boosted their price objective on shares of CME Group from $175.00 to $190.00 and gave the company a “neutral” rating in a research report on Wednesday, June 5th. Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price objective for the company. in a research report on Monday, May 27th. BidaskClub raised shares of CME Group from a “strong sell” rating to a “sell” rating in a research report on Wednesday, April 3rd. Rosenblatt Securities downgraded shares of CME Group from a “neutral” rating to a “sell” rating in a research report on Thursday, April 18th. Finally, ValuEngine downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research report on Wednesday, March 20th. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and eight have issued a buy rating to the company. CME Group presently has an average rating of “Hold” and an average target price of $190.67.
A number of institutional investors have recently bought and sold shares of CME. Weaver Consulting Group acquired a new stake in shares of CME Group in the 1st quarter worth approximately $70,000. WealthPLAN Partners LLC lifted its stake in shares of CME Group by 7.2% in the 1st quarter. WealthPLAN Partners LLC now owns 2,471 shares of the financial services provider’s stock worth $449,000 after acquiring an additional 165 shares during the period. FMR LLC lifted its stake in shares of CME Group by 5.7% in the 1st quarter. FMR LLC now owns 6,553,654 shares of the financial services provider’s stock worth $1,078,600,000 after acquiring an additional 355,566 shares during the period. Horizon Investments LLC lifted its stake in shares of CME Group by 20.6% in the 1st quarter. Horizon Investments LLC now owns 15,470 shares of the financial services provider’s stock worth $2,546,000 after acquiring an additional 2,647 shares during the period. Finally, Front Row Advisors LLC lifted its stake in shares of CME Group by 1.5% in the 1st quarter. Front Row Advisors LLC now owns 8,822 shares of the financial services provider’s stock worth $1,452,000 after acquiring an additional 130 shares during the period. 84.67% of the stock is owned by hedge funds and other institutional investors.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Featured Story: What are the benefits of buying treasury bonds?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.